Physicians' Academy for Cardiovascular Education

Expanding the role of lipid management: Current and Future

3' education - Oct. 25, 2011


Dr. Kees Hovingh, internist, Academic Medical Centre, Amsterdam, The Netherlands, discusses current and future targets in lipid management.
Questions to be addressed in this PACE expert opinion are:
  • What is the interaction between lipid particles and onset of atherogenicity?
  • What can we learn from clinical trials to define current and future targents in management of dyslipidemia?


Share this page with your colleagues and friends: